December 08, 2008 --Cambridge Laboratories Limited, the privately-owned specialty pharmaceutical company, today announces that its flagship product Tetrabenazine, has received marketing approval in Spain from the Agencia Espanola de Medicamentos y Productos Sanitarios.
The details can be read here.
No comments:
Post a Comment